The Efficacy of Retinoic Acid in Patients with Radioiodine-Refractory Thyroid Cancer: A Meta-analysis

被引：0
|
作者：
Shin, Seunghyeon [1 ]
Pak, Kyoungjune [1 ]
Kim, Seong-Jang [1 ]
Kim, In Joo [1 ]
机构：
[1] Pusan Natl Univ Hosp, Busan, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1702
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Exposure-response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancer
    Hayato, Seiichi
    Shumaker, Robert
    Ferry, Jim
    Binder, Terri
    Dutcus, Corina E.
    Hussein, Ziad
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (06) : 971 - 978
  • [22] Targeted therapy in patients with radioiodine-refractory differentiated thyroid cancer (DTC)
    Herceg, Davorin
    Herceg, Gordana Horvatic
    PERIODICUM BIOLOGORUM, 2014, 116 (04) : 399 - 407
  • [23] Treatment of Patients with Radioiodine-Refractory, differentiated Thyroid Cancer A Consensus Statement
    Lindner, C.
    Dierneder, J.
    Pall, G.
    Pirich, C.
    Hoffmann, M.
    Raderer, M.
    Becherer, A.
    Niederle, B.
    Lipp, R.
    Lind, P.
    Gallowitsch, H.
    Romeder, F.
    Virgolini, I.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (03): : 125 - 130
  • [24] Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
    Schlumberger, Martin
    Tahara, Makoto
    Wirth, Lori J.
    Robinson, Bruce
    Brose, Marcia S.
    Elisei, Rossella
    Habra, Mouhammed Amir
    Newbold, Kate
    Shah, Manisha H.
    Hoff, Ana O.
    Gianoukakis, Andrew G.
    Kiyota, Naomi
    Taylor, Matthew H.
    Kim, Sung-Bae
    Krzyzanowska, Monika K.
    Dutcus, Corina E.
    de las Heras, Begona
    Zhu, Junming
    Sherman, Steven I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07) : 621 - 630
  • [25] Tumor growth rate and lenvatinib efficacy in radioiodine-refractory differentiated thyroid cancer
    Leboulleux, S.
    Lee, E. K.
    Bastholt, L.
    Tahara, M.
    Wirth, L. J.
    Sherman, S. I.
    Robinson, B. G.
    Teng, A.
    Joshi, P.
    Misir, S.
    Dutcus, C. E.
    Tuttle, R. M.
    Schlumberger, M. J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] Radioiodine-refractory thyroid cancer, looking for predictive factors
    Guiote Moreno, M.
    Santos Bueno, A. M.
    Marquez Fernandez, J.
    Prieto Prieto, J. C.
    Albala Gonzalez, M.
    Rodriguez Caceres, E.
    Carlos Zamora, R.
    Vallejo Casas, J. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S142 - S142
  • [27] Letter to the editors on 'Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: A systematic review and meta-analysis of clinical trials'
    Li, Yan-Rong
    Wang, Shang-Yu
    Yeh, Chun-Nan
    CLINICAL ENDOCRINOLOGY, 2023, 98 (01) : 133 - 133
  • [28] Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
    Ovcaricek, Petra Petranovic
    Campenni, Alfredo
    de Keizer, Bart
    Deandreis, Desiree
    Kreissl, Michael C.
    Vrachimis, Alexis
    Tuncel, Murat
    Giovanella, Luca
    CANCERS, 2023, 15 (17)
  • [29] Lenvatinib and radioiodine-refractory thyroid cancers
    Lara Dunn
    James A. Fagin
    Nature Reviews Endocrinology, 2015, 11 : 325 - 327
  • [30] Exploratory analysis of prognostic factors for lenvatinib in radioiodine-refractory differentiated thyroid cancer
    Suzuki, Chiaki
    Kiyota, Naomi
    Imamura, Yoshinori
    Goto, Hideaki
    Suto, Hirotaka
    Chayahara, Naoko
    Toyoda, Masanori
    Ito, Yasuhiro
    Miya, Akihiro
    Miyauchi, Akira
    Otsuki, Naoki
    Nibu, Ken-ichi
    Minami, Hironobu
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (09): : 3023 - 3032
12345